HCSG — Healthcare Services Group Inc. stock price and chart

HCSG

$21.50+1.85%

as of close, Oct 20, 2026

☾ AH $21.50 +1.85%

Healthcare Services Group Inc.Stock · HealthcareRussell 2000 · 0.05% of IWMNasdaq Composite · 0.006% of ONEQRussell 3000 · 0.003% of IWVUS Stock Market · 0.002% of VTI

PeersMRNALLYMDTUNHJNJTMO

Share this page

Technical analysis2

Overlay lines0

Addendum charts0

VolumeDDDDDDDDDDDDDDDDDDDDDDDDDEEEEEEEEEEE

20162019202120242026

10.015.020.025.030.035.040.045.050.055.0010.0M20.0M$21.50

2026-10-20

Price$21.50

MA20$22.18

MA50$19.98

Vol2.6M

What would $1,000 invested in HCSG be worth today? →

HCSG returns: By year · By month · By week · Trailing

Key stats#

Price data

Price: $21.50
YTD price return: +12.45%
YTD total return: +12.45%
Next earnings: Oct 21, 2026 · Before open
Market cap: 1.5B2016-12 2.8B2026-10 1.5B-48.1% over the window
Enterprise value: 1.3B
Shares outstanding: 68.6M2016-06 72.5M2026-06 68.6M-5.3% over the window
52W low: $16.27
52W high: $25.75
From 52W high: -16.50%
From 52W low: +32.15%
52W range: 55%

Volume

Rel volume: 1.05×
30D volume: 706.2K
30D $ vol: 15M

Fundamentals

Sales (ttm): 1.9B2016-06 1.5B2026-06 1.9B+24.5% over the window
Sales/share: $27.172016-06 $20.672026-06 $27.17+31.5% over the window
EPS (ttm): $1.722016-06 $0.892026-06 $1.72+93.5% over the window
FCF (ttm): 148.5M2016-06 44.4M2026-06 148.5M+234.6% over the window
FCF/share: $2.162016-06 $0.612026-06 $2.16+253.2% over the window
Book value/share: $7.562016-06 $4.452026-06 $7.56+69.7% over the window
Net margin: 6.59%2016-06 4.2%2026-06 6.6%+55.3% over the window
ROE: 23.70%2016-06 19.7%2026-06 23.7%+20.2% over the window
ROA: 14.98%2016-06 12.2%2026-06 15.0%+23.1% over the window
Current ratio: 3.022016-06 3.772026-06 3.02-19.8% over the window

Growth (CAGR, ttm) · 10Y

Sales: +5.22%2025-06-30 → 2026-06-301.8B → 1.9B (+5.2% total)+3.64%2023-06-30 → 2026-06-301.7B → 1.9B (+11.3% total)+2.29%2021-06-30 → 2026-06-301.7B → 1.9B (+12.0% total)+2.22%2016-06-30 → 2026-06-301.5B → 1.9B (+24.5% total)
Net income: +1039.09%2025-06-30 → 2026-06-3010.8M → 123M (+1037.2% total)+50.56%2023-06-30 → 2026-06-3036M → 123M (+241.4% total)+6.53%2021-06-30 → 2026-06-3089.6M → 123M (+37.2% total)+6.81%2016-06-30 → 2026-06-3063.6M → 123M (+93.3% total)
FCF: +63.50%2025-06-30 → 2026-06-3090.9M → 148.5M (+63.4% total)n/a-0.07%2021-06-30 → 2026-06-30149.1M → 148.5M (-0.4% total)+12.84%2016-06-30 → 2026-06-3044.4M → 148.5M (+234.6% total)
Shares: -5.22%2025-06-30 → 2026-06-3072.4M → 68.6M (-5.2% total)-2.56%2023-06-30 → 2026-06-3074.2M → 68.6M (-7.5% total)-1.67%2021-06-30 → 2026-06-3074.7M → 68.6M (-8.1% total)-0.54%2016-06-30 → 2026-06-3072.5M → 68.6M (-5.3% total)

Per-share growth (CAGR, ttm) · 10Y

EPS: +1076.79%2025-06-30 → 2026-06-30$0.15 → $1.72 (+1074.8% total)+52.68%2023-06-30 → 2026-06-30$0.48 → $1.72 (+256.0% total)+7.59%2021-06-30 → 2026-06-30$1.19 → $1.72 (+44.2% total)+6.83%2016-06-30 → 2026-06-30$0.89 → $1.72 (+93.5% total)
Sales/share: +11.02%2025-06-30 → 2026-06-30$24.47 → $27.17 (+11.0% total)+6.37%2023-06-30 → 2026-06-30$22.57 → $27.17 (+20.4% total)+4.03%2021-06-30 → 2026-06-30$22.30 → $27.17 (+21.8% total)+2.77%2016-06-30 → 2026-06-30$20.67 → $27.17 (+31.5% total)
FCF/share: +72.52%2025-06-30 → 2026-06-30$1.25 → $2.16 (+72.5% total)n/a+1.62%2021-06-30 → 2026-06-30$2.00 → $2.16 (+8.4% total)+13.45%2016-06-30 → 2026-06-30$0.61 → $2.16 (+253.2% total)
Book value/share: +14.77%2025-06-30 → 2026-06-30$6.59 → $7.56 (+14.8% total)+8.32%2023-06-30 → 2026-06-30$5.95 → $7.56 (+27.1% total)+2.94%2021-06-30 → 2026-06-30$6.54 → $7.56 (+15.6% total)+5.43%2016-06-30 → 2026-06-30$4.45 → $7.56 (+69.7% total)
Dividend/share: -74.33%2022-09-30 → 2023-09-30$0.84 → $0.22 (-74.3% total)-35.68%2020-09-30 → 2023-09-30$0.81 → $0.22 (-73.4% total)-22.47%2018-09-30 → 2023-09-30$0.77 → $0.22 (-72.0% total)n/a
Price: +30.72%2025-10-20 → 2026-10-20$16.45 → $21.50 (+30.7% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+29.19%2023-10-20 → 2026-10-20$9.97 → $21.50 (+115.6% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+1.44%2021-10-20 → 2026-10-20$20.02 → $21.50 (+7.4% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-5.35%2016-10-19 → 2026-10-20$37.27 → $21.50 (-42.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.
Total return: +30.72%2025-10-20 → 2026-10-20$16.45 → $21.50 (+30.7% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+29.19%2023-10-20 → 2026-10-20$9.97 → $21.50 (+115.6% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+2.80%2021-10-20 → 2026-10-20$18.72 → $21.50 (+14.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-3.54%2016-10-19 → 2026-10-20$30.82 → $21.50 (-30.2% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.: 12.5×2016-12 42.932026-10 12.00-72.0% over the window
Fwd P/E: 17.4×
P/S (ttm)Market cap ÷ TTM revenue.: 0.8×2016-12 1.862026-10 0.79-57.4% over the window
P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.: 2.8×2016-12 8.592026-10 2.84-66.9% over the window
P/FCF (ttm)Market cap ÷ TTM free cash flow (operating cash flow − capex).: 9.9×2016-12 64.882026-10 9.93-84.7% over the window
EV/Sales (ttm): 0.7×
FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.: 10.07%2016-09 1.5%2026-06 8.8%+471.7% over the window
Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 68.6M ÷ 72.4M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.: 5.22%
Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (5.22%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1.1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.: 5.22%
Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($91.8M) ÷ today's market cap ($1.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.: 6.22%2016-09 -0.0%2026-06 5.4%-135880.6% over the window
Shareholder yield (cash, ttm)(TTM buybacks net of issuance $91.8M + TTM dividends $0) ÷ today's market cap ($1.5B). Same caveat as the cash buyback yield.: 6.22%2016-09 1.9%2026-06 5.4%+193.3% over the window

Vs own 10Y history

P/E: 1st
P/S: 43rd
P/B: 42nd
P/FCF: 11th

Bar = where today’s multiple sits in HCSG’s own 10-year range:near a decade-low (cheap)→near a decade-high (rich).

Performance · price return · as of 2026-10-20#

+1.85%

+2.92%

+0.14%

-13.83%

YTD

+12.45%

+30.70%

+7.39%

Financial statements

Open full HCSG financials →

Loading financial statements…

Ticker	Name	1M	1D
LLY	Eli Lilly and Company	+11.34%	+3.49%
JNJ	Johnson & Johnson	-3.94%	+2.19%
ABBV	AbbVie Inc.	+9.52%	+2.26%
UNH	UnitedHealth Group Incorporated Common Stock (DE)	+11.24%	+3.04%
MRK	Merck & Co. Inc.	+0.97%	+3.25%
NVS	Novartis AG	+9.45%	+2.29%
TMO	Thermo Fisher Scientific Inc.	+5.51%	+1.18%
AMGN	Amgen Inc.	+13.82%	+3.29%

HCSG — Healthcare Services Group Inc. price, chart and key statistics